<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Dis.</journal-id>
<journal-title-group>
<journal-title>Neurobiology of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0969-9961</issn>
<issn pub-type="epub">1095-953X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30008368</article-id>
<article-id pub-id-type="pmc">6415549</article-id>
<article-id pub-id-type="doi">10.1016/j.nbd.2018.07.004</article-id>
<article-id pub-id-type="manuscript">NIHMS1010690</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Reduced axonal surface expression and phosphoinositide sensitivity in K<sub>v</sub>7 channels disrupts their function to inhibit neuronal excitability in <italic>Kcnq2</italic> epileptic encephalopathy.</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Eung Chang</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jiaren</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pang</surname>
<given-names>Weilun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Shuwei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Kwan Young</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cavaretta</surname>
<given-names>John P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walters</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Procko</surname>
<given-names>Erik</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsai</surname>
<given-names>Nien-Pei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chung</surname>
<given-names>Hee Jung</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.</aff>
<aff id="A2"><label>2</label>Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.</aff>
<aff id="A3"><label>3</label>Neuroscience Program, and University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.</aff>
<author-notes>
<fn fn-type="equal" id="FN1">
<label>*</label>
<p id="P1">These authors contributed equally.</p>
</fn>
<corresp id="CR1"><bold>CORRESPONDING AUTHOR:</bold> Hee Jung Chung, Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 407 South Goodwin Avenue, 524 Burrill Hall, Urbana, IL 61801, USA.Telephone number: (217) 244-6839, <email>chunghj@life.illinois.edu</email>; <email>chunghj@illinois.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P57"><bold>DECLARATIONS OF INTERESTS:</bold> None</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>118</volume>
<fpage>76</fpage>
<lpage>93</lpage>
<!--elocation-id from pubmed: 10.1016/j.nbd.2018.07.004-->
<abstract id="ABS1">
<p id="P3">Neuronal K<sub>v</sub>7/KCNQ channels are voltage-gated potassium channels composed of K<sub>v</sub>7.2/KCNQ2 and K<sub>v</sub>7.3/KCNQ3 subunits. Enriched at the axonal membrane, they potently suppress neuronal excitability. <italic>De novo</italic> and inherited dominant mutations in K<sub>v</sub>7.2 cause early onset epileptic encephalopathy characterized by drug resistant seizures and profound psychomotor delay. However, their precise pathogenic mechanisms remain elusive. Here, we investigated selected epileptic encephalopathy causing mutations in calmodulin (CaM)-binding helices A and B of K<sub>v</sub>7.2. We discovered that R333W, K526N, and R532W mutations located peripheral to CaM contact sites decreased axonal surface expression of heteromeric channels although only R333W mutation reduced CaM binding to K<sub>v</sub>7.2. These mutations also altered gating modulation by phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>), revealing novel PIP<sub>2</sub> binding residues. While these mutations disrupted K<sub>v</sub>7 function to suppress excitability, hyperexcitability was observed in neurons expressing K<sub>v</sub>7.2-R532W that displayed severe impairment in voltage-dependent activation. The M518V mutation at the CaM contact site in helix B caused most defects in K<sub>v</sub>7 channels by severely reducing their CaM binding, K<sup>+</sup> currents, and axonal surface expression. Interestingly, the M518V mutation induced ubiquitination and accelerated proteasome-dependent degradation of K<sub>v</sub>7.2, whereas the presence of K<sub>v</sub>7.3 blocked this degradation. Furthermore, expression of K<sub>v</sub>7.2-M518V increased neuronal death. Together, our results demonstrate that epileptic encephalopathy mutations in helices A and B of K<sub>v</sub>7.2 cause abnormal K<sub>v</sub>7 expression and function by disrupting K<sub>v</sub>7.2 binding to CaM and/or modulation by PIP<sub>2</sub>. We propose that such multiple K<sub>v</sub>7 channel defects could exert more severe impacts on neuronal excitability and health, and thus serve as pathogenic mechanisms underlying <italic>Kcnq2</italic> epileptic encephalopathy.</p>
</abstract>
<kwd-group>
<kwd>K<sub>v</sub>7 channels</kwd>
<kwd>
<italic>Kcnq2</italic>
</kwd>
<kwd>epileptic encephalopathy</kwd>
<kwd>mutation</kwd>
<kwd>calmodulin</kwd>
<kwd>phosphoinositide</kwd>
<kwd>excitability</kwd>
<kwd>surface expression</kwd>
<kwd>current</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>